EXCLUSIVE IP LICENSE AGREEMENT FOR RQ-00000007Exclusive Ip License Agreement • June 6th, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 6th, 2013 Company Industry JurisdictionThis EXCLUSIVE IP LICENSE AGREEMENT FOR RQ-00000007 (this “Agreement”) is entered into as of December 27 2010 (the “Effective Date”) by and between. Aratana Therapeutics Inc., a Delaware corporation having a place of business is 1901 Olathe Boulevard, Kansas City, KS 66103 (“Licensee”) and RaQualia Pharma Inc., a Japanese corporation having a place of business at 5-2 Taketoyo, Aichi 470-2341, Japan (“Licensor”).
EXCLUSIVE IP LICENSE AGREEMENT FOR RQ-00000007Exclusive Ip License Agreement • April 11th, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 11th, 2013 Company Industry JurisdictionThis EXCLUSIVE IP LICENSE AGREEMENT FOR RQ-00000007 (this “Agreement”) is entered into as of December 27 2010 (the “Effective Date”) by and between. Aratana Therapeutics Inc., a Delaware corporation having a place of business is 1901 Olathe Boulevard, Kansas City, KS 66103 (“Licensee”) and RaQualia Pharma Inc., a Japanese corporation having a place of business at 5-2 Taketoyo, Aichi 470-2341, Japan (“Licensor”).